Clinical Trial Update: Pembrolizumab in Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of pembrolizumab in biliary tract cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cancer
• Gallbladder Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Biliary Tract Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED